Fig. 2From: Outcome and risk of recurrence in a large cohort of idiopathic longitudinally extensive transverse myelitis without AQP4/MOG antibodiesFlow-chart of the therapeutic strategy. LETM, longitudinal extensive transverse myelitisBack to article page